Mankind Pharma management will conduct in-person investor meetings in Singapore on May 25-26, 2026.
The company confirmed no unpublished price sensitive information will be shared during these meetings.
Discussions will focus on general business outlook and publicly available information only.
The meeting schedule is subject to change due to exigencies on either side.